This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 May 19;379(9829):1875; author reply 1876.

doi: 10.1016/S0140-6736(12)60805-8.

Intravenous salbutamol in ARDS and increased mortality

Fekri Abroug, Lamia Ouanes Besbes, Islem Ouanes, Fahmi Dachraoui

PMID: 22608332
DOI: 10.1016/S0140-6736(12)60805-8

Comment

Intravenous salbutamol in ARDS and increased mortality

Fekri Abroug et al. Lancet. 2012.

. 2012 May 19;379(9829):1875; author reply 1876.

doi: 10.1016/S0140-6736(12)60805-8.

Authors

Fekri Abroug, Lamia Ouanes Besbes, Islem Ouanes, Fahmi Dachraoui

PMID: 22608332
DOI: 10.1016/S0140-6736(12)60805-8

No abstract available

PubMed Disclaimer

Comment on

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.
Gao Smith F, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE; BALTI-2 study investigators. Gao Smith F, et al. Lancet. 2012 Jan 21;379(9812):229-35. doi: 10.1016/S0140-6736(11)61623-1. Epub 2011 Dec 11. Lancet. 2012. PMID: 22166903 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science